Third Rock Ventures Iii, L.P. Relay Therapeutics, Inc. (RLAY) insider trading activity

Third Rock Ventures Iii, L.P. is > 10% Shareholder of Relay Therapeutics, Inc.. Currently has a direct ownership of 7.74 Million shares of RLAY, which is worth approximately $45.2 Million. The most recent transaction as insider was on Jan 13, 2021, when has been sold 1,311,197 shares (Common Stock) at a price of $42.39 per share, resulting in proceeds of $55,581,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.74M

0% 3M change

0% 12M change

Total Value Held $45.2 Million

Third Rock Ventures III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 13 2021	SELL Open market or private sale	$55,581,640 $42.39 p/Share	1,311,197 Reduced 14.49%	7,739,918 Common Stock
Jan 12 2021	SELL Open market or private sale	$60,000,000 $40.0 p/Share	1,500,000 Reduced 14.22%	9,051,115 Common Stock
Jul 20 2020	BUY Conversion of derivative security	-	9,987,881 Added 50.0%	9,987,881 Common Stock

Also insider at

MYOK

MyoKardia Inc

> 10% Shareholder

VYGR

Voyager Therapeutics, Inc. Healthcare

> 10% Shareholder

NTGN

Neon Therapeutics, Inc.

> 10% Shareholder

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

> 10% Shareholder

NRIX

Nurix Therapeutics, Inc. Healthcare

> 10% Shareholder

JNCE

Jounce Therapeutics, Inc. Healthcare

> 10% Shareholder

TRV